EGFR-RAS-MAPK signaling is confined to the plasma membrane and associated endorecycling protrusions.
Sachin SurveSimon C WatkinsAlexander SorkinPublished in: The Journal of cell biology (2021)
The subcellular localization of RAS GTPases defines the operational compartment of the EGFR-ERK1/2 signaling pathway within cells. Hence, we used live-cell imaging to demonstrate that endogenous KRAS and NRAS tagged with mNeonGreen are predominantly localized to the plasma membrane. NRAS was also present in the Golgi apparatus and a tubular, plasma-membrane derived endorecycling compartment, enriched in recycling endosome markers (TERC). In EGF-stimulated cells, there was essentially no colocalization of either mNeonGreen-KRAS or mNeonGreen-NRAS with endosomal EGFR, which, by contrast, remained associated with endogenous Grb2-mNeonGreen, a receptor adaptor upstream of RAS. ERK1/2 activity was diminished by blocking cell surface EGFR with cetuximab, even after most ligand-bound, Grb2-associated EGFRs were internalized. Endogenous mCherry-tagged RAF1, an effector of RAS, was recruited to the plasma membrane, with subsequent accumulation in mNG-NRAS-containing TERCs. We propose that a small pool of surface EGFRs sustain signaling within the RAS-ERK1/2 pathway and that RAS activation persists in TERCs, whereas endosomal EGFR does not significantly contribute to ERK1/2 activity.
Keyphrases
- wild type
- signaling pathway
- induced apoptosis
- pi k akt
- small cell lung cancer
- epidermal growth factor receptor
- cell cycle arrest
- tyrosine kinase
- cell proliferation
- epithelial mesenchymal transition
- cell surface
- high resolution
- magnetic resonance
- endoplasmic reticulum stress
- radiation therapy
- oxidative stress
- growth factor
- magnetic resonance imaging
- cell death
- immune response
- endoplasmic reticulum
- dendritic cells
- photodynamic therapy